Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

Rigel Pharmaceuticals, Inc. (RIGL) grants 377,900 stock options to non-executive employees as an inducement for employment, in accordance with NASDAQ Listing Rule 5635(c)(4).

SOUTH SAN FRANCISCO, Calif., Jan. 5, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees' entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4). Specifically, Rigel granted 377,900 stock options to four non-executive employees vesting over four years with a one-year cliff.  

Rigel is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com. 

Investors & Media Contacts
Investors:
Rigel Pharmaceuticals, Inc. 
650.624.1232
ir@rigel.com

Media:
David Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302027467.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

What did Rigel Pharmaceuticals, Inc. (RIGL) announce?

Rigel Pharmaceuticals, Inc. (RIGL) announced the granting of 377,900 stock options to non-executive employees as an inducement for employment.

How many stock options were granted by Rigel Pharmaceuticals, Inc. (RIGL)?

Rigel Pharmaceuticals, Inc. (RIGL) granted 377,900 stock options to non-executive employees.

What is the vesting period for the stock options granted by Rigel Pharmaceuticals, Inc. (RIGL)?

The stock options granted by Rigel Pharmaceuticals, Inc. (RIGL) vest over four years with a one-year cliff.

Why did Rigel Pharmaceuticals, Inc. (RIGL) provide this information?

Rigel Pharmaceuticals, Inc. (RIGL) provided this information in accordance with NASDAQ Listing Rule 5635(c)(4).